Ryan Cohlhepp, President and COO at Bicara Therapeutics Inc. (BCAX), sold 28,750 shares at $28.76 ($833K) on 2026-07-08, disclosed to the SEC on 2026-07-10.
Scheduled sale ($833k) by President and COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.76 | 22,833 | $657K | 78.8% |
| 2 | $29.80 | 4,306 | $128K | 15.4% |
| 3 | $30.35 | 1,075 | $33K | 3.9% |
| 4 | $29.00 | 536 | $16K | 1.9% |
| Total | $28.98 avg | 28,750 | $833K | 100% |
| Filing → |
| BCAX | SELL | 2026-05-18 | $254K | — | Filing → |
| BCAX | SELL | 2026-04-17 | $288K | — | Filing → |
| BCAX | SELL | 2026-03-17 | $491K | — | Filing → |